4//SEC Filing
Wellborn Gayle Furgurson 4
Accession 0001712960-25-000004
CIK 0001428336other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 3:44 PM ET
Size
10.5 KB
Accession
0001712960-25-000004
Insider Transaction Report
Form 4
Wellborn Gayle Furgurson
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-12$50.41/sh+4,339$218,729→ 24,072 total - Sale
Common Stock
2025-12-12$98.03/sh−4,339$425,331→ 19,733 total - Exercise/Conversion
Stock Options (right to buy)
2025-12-12−4,339→ 0 totalExercise: $50.41Exp: 2028-02-01→ Common Stock (4,339 underlying)
Holdings
- 2,439
Stock Option (right to buy)
Exercise: $47.21Exp: 2027-08-01→ Common Stock (2,439 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.87 to $98.20 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
- [F2]The option is immediately exercisable.
Documents
Issuer
HEALTHEQUITY, INC.
CIK 0001428336
Entity typeother
Related Parties
1- filerCIK 0001712960
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 3:44 PM ET
- Size
- 10.5 KB